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The PPROMEXIL trials compared
‘immediate delivery’, involving
induction of labour (IOL) within
48 hours of randomisation with
expectant management (EM) for 723
women who were not in labour but
had ruptured membranes for more
than 24 hours between 34 and
37 weeks of gestation (van der Ham
et al. Plos Med 2012;9:e1001208; van
der Ham et al. Am J Obset Gynecol
2012;207:276. e1–10). No signiﬁcant
reduction was found in the risk of
early neonatal sepsis (within
72 hours of birth and measured by a
positive blood culture with symp-
toms or laboratory measures of
infection). In the accompanying
paper, Tajik et al. report a post hoc
analysis to determine whether the
effect of IOL differed according to
whether women were colonised with
group B streptococci (GBS) or not.
Among the 13% of women
(n = 103) colonised with GBS, they
found a reduction in neonatal sepsis
from 15.2% (7/46) in the EM group
to 1.8% (1/57) in the IOL group.
Rates of neonatal sepsis were similar
in the EM and IOL groups of
women who were not colonised with
GBS (2.6%; 8/313 EM versus 2.9%
9/306 IOL group). However, rates of
clinical and histological chorioam-
nionitis were reduced by IOL in both
GBS colonised (clinical 10.9% EM to
5.4% IOL) and noncolonised women
(clinical 4.5% EM to 1.0% IOL). All
of these differences were signiﬁcant
at the 5% level.
A key question for practitioners is
whether women with PPROM who
were managed by EM or IOL were
already receiving prenatal antibiotic
prophylaxis. Based on a systematic
review of randomised trials (Kenyon
et al. Cochrane Database Sys Rev
2013;12:CD001058), prenatal antibi-
otics are recommended for PPROM
regardless of maternal GBS status
because they signiﬁcantly prolong
pregnancy and reduce neonatal infec-
tion (sepsis or pneumonia), chorio-
amnionitis and abnormal neonatal
cerebral ultrasound scans. However,
the PPROMEXIL trials allowed prena-
tal antibiotics to be administered
according to local protocols and in
most cases, these were administered
empirically, without knowledge of
maternal culture results. However,
substantially more GBS-colonised
women received antibiotics (89%; 40/
45 EM versus 69% 39/56 IOL), than
those who were not GBS colonised
(37% 119/305 EM versus 37% 111/
303 IOL group). Not surprisingly,
given the low rates of antibiotics used
in the non-GBS-colonised women
and their larger numbers, more cases
of neonatal sepsis occurred in
non-GBS-colonised women (n = 17)
than in the GBS-colonised women
(n = 8). There were also many more
cases of clinical chorioamnionitis
(8 GBS, 17 non-GBS) and histological
chorioamnionitis (27 GBS, 110 non-
GBS) in the non-GBS-colonised
women. Chorioamnionitis is an impor-
tant outcome because it is associated
with an increased risk of cerebral
palsy of between 40% and 400% in
late preterm births, depending on the
duration of membrane rupture (Wu
et al. JAMA 2003;290:2677–84).
Tajik et al.’s data show the conun-
drum. They propose IOL in GBS-col-
onised women but this would focus on
a small group of high-risk, colonised
women and miss most cases of neona-
tal sepsis. Moreover, prenatal screen-
ing to detect GBS colonisation in
women with PPROM could delay
treatment for those with GBS coloni-
sation,pendingtestresults,whichhave
limited accuracy, and the large num-
ber of GBS-negative women might not
receiveantibioticsatall.Thebestavail-
able evidence suggests that all women
with PPROM should be offered prena-
tal antibiotics, although if maternal
GBS status is known, the results from
Tajik et al. suggest there may be added
beneﬁt of early delivery.
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